This topic contains a solution. Click here to go to the answer

Author Question: When common emulsifiers function to mix lipid- and water-based ingredients, a. the glycerol ... (Read 60 times)

codyclark

  • Hero Member
  • *****
  • Posts: 538
When common emulsifiers function to mix lipid- and water-based ingredients,
 a. the glycerol molecules and hydroxyl groups in their structures are drawn to the lipid phase.
  b. the one or two fatty acids in their structures are drawn toward the lipid phase.
  c. their molecules are completely hydrophilic.
  d. the hydrophobic ends of their molecules attach to water.

Question 2

The lipoproteins of egg yolk are classified as
 a. both surfactants and good emulsifiers.
  b. surfactants but not good emulsifiers.
  c. good emulsifiers but not surfactants.
  d. neither surfactants nor good emulsifiers.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Carissamariew

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

b

Answer to Question 2

a




codyclark

  • Member
  • Posts: 538
Reply 2 on: Aug 19, 2018
Great answer, keep it coming :)


scikid

  • Member
  • Posts: 300
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library